241 related articles for article (PubMed ID: 26046734)
1. Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.
Jamasbi J; Megens RT; Bianchini M; Münch G; Ungerer M; Faussner A; Sherman S; Walker A; Goyal P; Jung S; Brandl R; Weber C; Lorenz R; Farndale R; Elia N; Siess W
J Am Coll Cardiol; 2015 Jun; 65(22):2404-15. PubMed ID: 26046734
[TBL] [Abstract][Full Text] [Related]
2. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
[TBL] [Abstract][Full Text] [Related]
3. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
[TBL] [Abstract][Full Text] [Related]
4. Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation.
Jamasbi J; Megens RT; Bianchini M; Uhland K; Münch G; Ungerer M; Sherman S; Faussner A; Brandl R; John C; Buchner J; Weber C; Lorenz R; Elia N; Siess W
JACC Basic Transl Sci; 2016 Apr; 1(3):131-142.. PubMed ID: 27766315
[TBL] [Abstract][Full Text] [Related]
5. Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments.
Lecut C; Feeney LA; Kingsbury G; Hopkins J; Lanza F; Gachet C; Villeval JL; Jandrot-Perrus M
J Thromb Haemost; 2003 Dec; 1(12):2653-62. PubMed ID: 14675102
[TBL] [Abstract][Full Text] [Related]
6. Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
Ebrahim M; Jamasbi J; Adler K; Megens RTA; M'Bengue Y; Blanchet X; Uhland K; Ungerer M; Brandl R; Weber C; Elia N; Lorenz R; Münch G; Siess W
Thromb Haemost; 2018 Feb; 118(2):351-361. PubMed ID: 29378359
[TBL] [Abstract][Full Text] [Related]
7. Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin.
Bültmann A; Li Z; Wagner S; Peluso M; Schönberger T; Weis C; Konrad I; Stellos K; Massberg S; Nieswandt B; Gawaz M; Ungerer M; Münch G
J Mol Cell Cardiol; 2010 Sep; 49(3):532-42. PubMed ID: 20430036
[TBL] [Abstract][Full Text] [Related]
8. Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood.
Jung SM; Moroi M; Soejima K; Nakagaki T; Miura Y; Berndt MC; Gardiner EE; Howes JM; Pugh N; Bihan D; Watson SP; Farndale RW
J Biol Chem; 2012 Aug; 287(35):30000-13. PubMed ID: 22773837
[TBL] [Abstract][Full Text] [Related]
9. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
[TBL] [Abstract][Full Text] [Related]
10. Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation.
Induruwa I; Moroi M; Bonna A; Malcor JD; Howes JM; Warburton EA; Farndale RW; Jung SM
J Thromb Haemost; 2018 Feb; 16(2):389-404. PubMed ID: 29210180
[TBL] [Abstract][Full Text] [Related]
11. Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice.
Grüner S; Prostredna M; Koch M; Miura Y; Schulte V; Jung SM; Moroi M; Nieswandt B
Blood; 2005 Feb; 105(4):1492-9. PubMed ID: 15507524
[TBL] [Abstract][Full Text] [Related]
12. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily.
Jandrot-Perrus M; Busfield S; Lagrue AH; Xiong X; Debili N; Chickering T; Le Couedic JP; Goodearl A; Dussault B; Fraser C; Vainchenker W; Villeval JL
Blood; 2000 Sep; 96(5):1798-807. PubMed ID: 10961879
[TBL] [Abstract][Full Text] [Related]
13. The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice.
Schönberger T; Siegel-Axel D; Bussl R; Richter S; Judenhofer MS; Haubner R; Reischl G; Klingel K; Münch G; Seizer P; Pichler BJ; Gawaz M
Cardiovasc Res; 2008 Oct; 80(1):131-7. PubMed ID: 18566102
[TBL] [Abstract][Full Text] [Related]
14. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo.
Schulz C; Penz S; Hoffmann C; Langer H; Gillitzer A; Schneider S; Brandl R; Seidl S; Massberg S; Pichler B; Kremmer E; Stellos K; Schönberger T; Siess W; Gawaz M
Basic Res Cardiol; 2008 Jul; 103(4):356-67. PubMed ID: 18431526
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
[TBL] [Abstract][Full Text] [Related]
16. Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation.
Jooss NJ; Smith CW; Slater A; Montague SJ; Di Y; O'Shea C; Thomas MR; Henskens YMC; Heemskerk JWM; Watson SP; Poulter NS
J Thromb Haemost; 2022 Nov; 20(11):2617-2631. PubMed ID: 35894121
[TBL] [Abstract][Full Text] [Related]
17. Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber.
Florian P; Wonerow P; Harder S; Kuczka K; Dubar M; Graff J
Eur J Clin Pharmacol; 2017 Aug; 73(8):949-956. PubMed ID: 28523478
[TBL] [Abstract][Full Text] [Related]
18. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques.
Reininger AJ; Bernlochner I; Penz SM; Ravanat C; Smethurst P; Farndale RW; Gachet C; Brandl R; Siess W
J Am Coll Cardiol; 2010 Mar; 55(11):1147-58. PubMed ID: 20223370
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein VI (GPVI)-functionalized nanoparticles targeting arterial injury sites under physiological flow.
Levi M; Epshtein M; Castor T; Gawaz M; Korin N
Nanomedicine; 2020 Oct; 29():102274. PubMed ID: 32712174
[TBL] [Abstract][Full Text] [Related]
20. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.
Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
